CTC1

Across TCGA pan-cancer cohorts, CTC1 Mutation is linked to patient survival in 6 of 34 cancer types, making it a survival-associated CTC1 data layer compared with 25 for mass-spec protein and 3 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher CTC1 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated CTC1 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC, SARC, and CESC are the cancer types where CTC1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	II,III,IV	0.933	0.436	.020	14	view →
SARC	OS	Median	All	0.174	0.745	.005	6	view →
CESC	OS	Median	III,IV	0.167	0.657	.044	6	view →
COAD	DFS	Median	II,III,IV	0.117	0.547	.012	4	view →
CHOL	OS	Median	All	0.155	0.725	.029	3	view →
LIHC	DFS	Median	All	0.096	0.555	.002	3	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

CTC1–UCEC (DFS)

Open the UCEC breakdown →